Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 21 Sept 2017 for NEKTAR THERAPEUTICS.
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
2
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +33.3%Entry 0.30 · Close at T+365 0.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Joseph J. Krivulka: trading record in brief
Joseph J. Krivulka discloses dealings in 2 companies, chiefly Nektar Therapeutics and Aeolus Pharmaceuticals, Inc. We count 10 filings; the first trade dates from 16 November 2007 and the latest from 19 September 2017.
No open-market sale appears; the market trades are 2 purchases worth €77k. The amount is not disclosed for 1 filing. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 3 share grants and 5 option exercises.
The newest entry dates from 21 September 2017: a share grant, in Nektar Therapeutics. The most recent open-market purchase was published on 20 February 2013, 4,994 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Joseph J. Krivulka
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
9,000 shares0Common StockSEC:0001209191-17-053615:0
15,000 shares@ US$8.37100.0% of flowCommon StockSEC:0001209191-17-042168:0
8,000 shares0Common StockSEC:0001209191-16-142666:0
15,000 shares0Common StockSEC:0001209191-16-142025:0
15,000 shares@ US$8.81Common StockSEC:0001209191-15-062661:0
400,000 sharesCommon Stock, $0.01 par value per shareSEC:0001102624-13-000218:0
Canonical exit: 20 May 2013 (T+90)
333,333 shares@ US$0.30Common Stock, $0.01 par value per shareSEC:0001102624-12-000285:0
Canonical exit: 4 Jul 2012 (T+90)
10,000 sharesCommon StockSEC:0001181431-11-016773:0
5,000 sharesCommon StockSEC:0001181431-08-062508:0
9 of 9 declarations
